Mixed oropharyngeal Candidiasis due to Candida albicans and non-albicans Candida strains in HIV-infected patients

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 15, Issue 6, 1996, Pages 446-452

  Dronda, F ^a   Alonso Sanz, M ^a   Laguna, F ^b   Chaves, F ^a   Martinez Suarez J V ^b   Rodriguez Tudela J L ^b   Gonzalez Lopez A ^a   Valencia, E ^b  

^a Hospital General Penitenciario   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CD4 ANTIGEN; FLUCONAZOLE; KETOCONAZOLE;

ADULT; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA TROPICALIS; CANDIDIASIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FUNGUS CULTURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MALE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; THRUSH;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CANDIDA; CANDIDIASIS, ORAL; FEMALE; FLUCONAZOLE; HUMANS; MALE; PHARYNGEAL DISEASES;

EID: 0030005321     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01691310     Document Type: Article

References (34)

1. Como JA, Dismukes WE: Oral azole drugs as systemic antifungal therapy. New England Journal of Medicine 1994, 330: 263-272.
2. Troke PF, Andrews RJ, Pye GW, Richardson K: Fluconazole and other azoles: translation of in vitro activity to in vivo and clinical efficacy. Reviews of Infectious Diseases 1990, 12, Supplement 3: 276-280.
3. Brammer KW, Farrow PR, Faulkner JK: Pharmokinetics and tissue penetration of fluconazole in humans. Reviews of Infectious Diseases 1990, 12, Supplement 3: 318-326.
4. Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R: Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. New England Journal of Medicine 1991, 325: 1274-1277.
5. Persons DA, Laughlin M, Tanner D, Perfect J, Gockerman JP, Hathorn JW: Fluconazole and Candida krusei fungemia. New England Journal of Medicine 1991, 325: 1315.
6. Warnock DW, Burke J, Cope NJ, Jonhson EM, Von Fraunhofer NA, Wiliams EW: Fluconazole resistance in Candida glabrata. Lancet 1988, ii: 1310.
7. Willocks L, Leen CLS, Brettle RP, Urquart D, Russell TB, Milne LJR: Fluconazole resistance in AIDS patients. Journal of antimicrobial Chemotherapy 1991, 28: 937-939.
8. Kitchen VS, Savage M, Harris JR: Candida albicans resistance in AIDS. Journal of Infection 1991, 22: 204-205.
9. Fox R, Neal KR, Leen CL, Ellis ME, Mendal BK: Fluconazole resistant Candida in AIDS. Journal of Infection 1991, 22: 201-204.
10. Dronda F, Rodríguez-Tudela JL, Mera P, Martínez-Suárez JV: Esofagitis por Candida albicans resistente a fluconazol: fallo terapéutico y correlación "in vitro". Medicina Clínica 1992, 99: 199.
11. Boken DJ, Swindells S, Rinaldi MG: Fluconazole-resistant Candida albicans. Clinical Infectious Diseases 1993, 17: 1018-1021.
12. Sanguineti A, Carmichael JK, Campbell K: Fluconazole-resistant Candida albicans after long-term suppressive therapy. Archives of Internal Medicine 1993, 153: 1122-1124.
13. Redding S, Smith J, Farinacci G, Rinaldi M, Fothergill A, Rhine-Chalberg J, Pfaller M: Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vivo susceptibility testing and DNA subtype analysis. Clinical Infectious Diseases 1994, 18: 240-242.
14. Rodríguez-Tudela JL, Martínez-Suárez JV, Dronda F, Laguna F, Chaves F, Valencia E: Correlation of in vitro susceptibility test results with clinical response: a study of azole therapy in AIDS patients. Journal of Antimicrobial Chemotherapy 1995, 35: 793-804.
15. Troillet N, Durussel C, Bille J, Glauser MP, Chave JP: Correlation between in vitro susceptibility of Candida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patients. European Journal of Clinical Microbiology & Infectious Diseases 1993, 12: 911-915.
16. Powderly WG: Mucosal candidiasis caused by non-albicans species of Candida in HIV-positive patients. AIDS 1992, 6: 604-605.
17. Newman SL, Flanigan TP, Fisher A, Rinaldi MG, Stein M, Vigilante K: Clinically significant mucosal candidiasis resistant to fluconazole treatment in patients with AIDS. Clinical Infectious Diseases 1994, 19: 684-686.
18. Rodríguez-Tudela JL, Martínez-Suárez JV: Defining conditions for microbroth antifungal susceptibility tests: influence of RPMI and RPMI-2% glucose on the selection of endpoint criteria. Journal of Antimicrobial Chemotherapy 1995, 35: 739-749.
19. Rodríguez-Tudela JL, Martínez-Suárez JV: Improved medium for fluconazole susceptibility testing of Candida albicans. Antimicrobial Agents and Chemotherapy 1994, 38: 45-48.
20. Pfaller MA, Burmeister L, Bartlett MS, Rinaldi MG: Multicenter evaluation of four methods of yeast inoculum preparation. Journal of Clinical Microbiology 1988, 26: 1437-1441.
21. Thorsen S, Mathiesen LR: Fluconazole for ketoconazole-resistant oropharyngeal candidiasis in HIV-1 infected patients. Scandinavian Journal of Infectious Diseases 1990, 22: 375-376.
22. De Wit S, Weerts D, Goosens H, Chunech N: Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS. Lancet 1989, i: 746-747.
23. Laine L, Dretler RH, Conteas CN, Tuazon C, Koster FM, Sattler F, Squires K, Islam MZ: Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS. A randomized trial. Annals of Internal Medicine 1992, 117: 655-660.
24. Tavitian A, Raufman JP, Roshental LE, Weber J, Webber CA, Dincsoy HP: Ketoconazole-resistant Candida esophagitis in patients with acquired immunodeficiency syndrome. Gastroenterology 1986, 90: 443-445.
25. Ruhnke M, Eigler A, Tonnagen I, Geiseler B, Engelmann E, Trautmann M: Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. Journal of Clinical Microbiology 1994, 32: 2092-2098.
26. Martínez-Suárez JV, Rodríguez-Tudela JL: Patterns of in vitro activity of itraconazole and imidazole antifungals against Candida albicans with decreased susceptibility to fluconazole from Spain. Antimicrobial Agents and Chemotherapy 1995, 39: 1512-1516.
27. Price MF, LaRocco MT, Gentry LO: Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period. Antimicrobial Agents and Chemotherapy 1994, 38: 1422-1424.
28. Rex JH, Bennett JE, Sugar AM, Pappas PG, Van der Horst CM, Edwards JE, Washburn RG, Scheld WM, Karchmer AW, Dine AP, Levenstein MJ, Webb CD, for the Candidemia Study Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group: A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. New England Journal of Medicine 1994, 331: 1325-1330.
29. Sangeorzan JA, Bradley SF, He Z, Zarins LT, Ridenour GL, Tiballi RN, Kauffman CA: Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment and emergence of fluconazole resistance. American Journal of Medicine 1994, 97: 339-346.
30. Baily GG, Perry FM, Denning DW, Mandel BK: Fluconazole-resistant candidosis in an HIV cohort. AIDS 1994, 8: 787-792.
31. Millon L, Manteaux A, Reboux G, Drobacheff C, Monod M, Barale T, Michel-Briand Y: Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype. Journal of Clinical Microbiology 1994, 32: 1115-1118.
32. Miyasaki SH, Hicks JB, Greenspan D, Polachek I, Mac-Phail LA, White TC, Agabian N, Greenspan JS: The identification and tracking of Candida albicans isolates from oral lesions in HIV-seropositive individuals. Journal of Acquired Immune Deficiency Syndromes 1992, 5: 1039-1046.
33. Sandven P, Bjorneklett A, Maeland A, and the Norwegian Yeast Study Group: Susceptibilities of Norwegian Candida albicans strains to fluconazole: emergence of resistance. Antimicrobial Agents and Chemotherapy 1993, 37: 2449-2453.
34. Pfaller MA: Epidemiology and control of fungal infections. Clinical Infectious Diseases 1994, 19, Supplement 1: 8-13.